6,718 Shares in Merit Medical Systems, Inc. $MMSI Purchased by Virtus Advisers LLC

Virtus Advisers LLC acquired a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,718 shares of the medical instruments supplier’s stock, valued at approximately $466,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp raised its stake in shares of Merit Medical Systems by 1.5% during the fourth quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock worth $196,645,000 after buying an additional 32,459 shares during the last quarter. Conestoga Capital Advisors LLC boosted its stake in Merit Medical Systems by 3.9% in the first quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock valued at $149,407,000 after acquiring an additional 81,030 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its stake in Merit Medical Systems by 12.7% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after acquiring an additional 234,682 shares during the last quarter. Wellington Management Group LLP grew its holdings in Merit Medical Systems by 7.0% during the 4th quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock worth $116,963,000 after acquiring an additional 86,504 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Merit Medical Systems by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock worth $85,287,000 after acquiring an additional 12,285 shares during the period. 99.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on MMSI shares. Robert W. Baird set a $98.00 price target on Merit Medical Systems in a research note on Friday, July 31st. Needham & Company LLC lifted their price objective on Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Wells Fargo & Company lifted their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. JPMorgan Chase & Co. upped their price objective on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Finally, Piper Sandler increased their target price on Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus price target of $100.00.

Merit Medical Systems Stock Down 1.9%

Shares of Merit Medical Systems stock opened at $90.27 on Friday. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The business has a 50-day moving average of $76.93 and a two-hundred day moving average of $72.44. The company has a market capitalization of $5.39 billion, a P/E ratio of 37.30, a price-to-earnings-growth ratio of 2.31 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The company had revenue of $418.84 million during the quarter, compared to analysts’ expectations of $405.25 million. During the same quarter in the prior year, the company earned $1.01 earnings per share. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts predict that Merit Medical Systems, Inc. will post 3.81 EPS for the current year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.